DEBASISH TRIPATHY to Triazoles
This is a "connection" page, showing publications DEBASISH TRIPATHY has written about Triazoles.
Connection Strength
0.205
-
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance). J Clin Oncol. 2016 08 01; 34(22):2602-9.
Score: 0.101
-
Co-targeting estrogen receptor and HER2 pathways in breast cancer. Breast. 2014 Feb; 23(1):2-9.
Score: 0.085
-
Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsiveness. Clin Cancer Res. 2012 Feb 01; 18(3):901-11.
Score: 0.019